Hematopoietic Stem Cell TransplantationTransplantation, AutologousStem Cell TransplantationTransplantation, HomologousHematopoietic Stem CellsTransplantation ConditioningPeripheral Blood Stem Cell TransplantationGraft vs Host DiseaseStem CellsMultiple MyelomaMelphalanHematologic NeoplasmsTreatment OutcomeCombined Modality TherapyBone Marrow TransplantationRemission InductionMyeloablative AgonistsAntineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem Cell MobilizationRecurrenceSalvage TherapyDisease-Free SurvivalWhole-Body IrradiationTransplantation ChimeraBusulfanGraft SurvivalRetrospective StudiesCyclophosphamideTissue DonorsSurvival RateLymphoma, Non-HodgkinHodgkin DiseaseAntigens, CD34EtoposideCytarabineCord Blood Stem Cell TransplantationLiver TransplantationSurvival AnalysisCarmustineThiotepaMesenchymal Stem Cell TransplantationHistocompatibility TestingVincristineHematopoiesisBone Marrow PurgingHistocompatibilityTime FactorsFollow-Up StudiesCell TransplantationGraft vs Leukemia EffectLeukemiaLeukemia, Myeloid, AcutePrognosisGranulocyte Colony-Stimulating FactorAmyloidosisEmbryonic Stem CellsLymphoma, Mantle-CellImmunosuppressive AgentsMyelodysplastic SyndromesCell DifferentiationChimerismKidney TransplantationAdult Stem CellsAntineoplastic Agents, AlkylatingDexamethasoneBoronic AcidsBone Marrow CellsPyrazinesAntibodies, Monoclonal, Murine-DerivedLymphoma, FollicularHepatic Veno-Occlusive DiseaseVidarabineLeukapheresisHematologic DiseasesStem Cell NicheNeoplasm, ResidualHLA AntigensLymphomaTransplantation ImmunologySiblingsAutograftsDoxorubicinBone MarrowGraft vs Tumor EffectThalidomidePrednisoneCell LineageLymphoma, T-Cell, PeripheralUnrelated DonorsFlow CytometryAntineoplastic AgentsLymphocyte TransfusionMesenchymal Stromal CellsTransplantation, IsogeneicPrecursor Cell Lymphoblastic Leukemia-LymphomaAcute DiseasePluripotent Stem CellsT-LymphocytesIfosfamidePodophyllotoxin